DURHAM, N.C. & SEATTLE-- November 13, 2023--Pioneering epigenome editing company Tune Therapeutics has announced it is working on a new and potentially curative approach to treating chronic HBV infection. The...
Art Pappas to participate at Foundation Sante Biotechnology Conference at Samos, Greece
News | 07. 11. 2008
© 2023 Pappas Capital, LLC. ALL RIGHTS RESERVED.